Strategies for subgroup analysis in clinical trials.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1007/978-3-642-83419-6_6PMID 3175311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of the proportionate mortality index in the presence of multiple comparisons.

  1987cited by this paper
• Testing for qualitative interactions between treatment effects and patient subsets.

  1985cited by this paper
• Assessing apparent treatment--covariate interactions in randomized clinical trials.

  1985cited by this paper
• Clinical Trials: A Practical Approach

  1984cited by this paper

• Clinical Trials of Heart Failure - Is there a question of sex?

  2021cites this paper
• Development of predictive signatures for treatment selection in precision medicine with survival outcomes

  2018cites this paper
• Interpretation of subgroup results in clinical trial publications: insights from a survey of medical specialists in Ontario, Canada.

  2006cites this paper
• Differential Treatment Benefit of Platelet Glycoprotein IIb/IIIa Inhibition With Percutaneous Coronary Intervention Versus Medical Therapy for Acute Coronary Syndromes: Exploration of Methods

  2004cites this paper
• Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.

  2004cites this paper
• The relationship between prognostic and predictive factors in the management of breast cancer

  2004cites this paper
• Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial).

  2003cites this paper
• The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.

  2002cites this paper
• Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

  2001cites this paper
• Subgroups, treatment effects, and baseline risks: some lessons from major cardiovascular trials.

  2000cites this paper
• Issues of Interpretation Arising from Analyses of Multiple Subgroups in Clinical Trials

  1993cites this paper
• Comparison of the Cox model and the regression tree procedure in analysing a randomized clinical trial.

  1993cites this paper